UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3
- Status
- COMPLETED
- Phase
- PHASE2
A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L
- Status
- COMPLETED
- Phase
- PHASE2